首页> 外文期刊>The Open Hypertension Journal >Can We Tackle with Vascular Calcification and Arterial Stiffness in Patients with Chronic Kidney Disease?
【24h】

Can We Tackle with Vascular Calcification and Arterial Stiffness in Patients with Chronic Kidney Disease?

机译:慢性肾脏病患者能否应对血管钙化和动脉僵硬?

获取原文
       

摘要

Cardiovascular disease remains the leading cause of increased morbidity and mortality in patients with chronickidney disease and is attributed to early and accelerated atherosclerosis and arteriosclerosis observed in this patient population.Vascular calcifications, particularly of the media, are commonly found in chronic uremia and are a major contributorto arteriosclerosis and increased arterial stiffness. Epidemiologic data support the correlation of vascular calcificationand arterial stiffness to adverse cardiovascular outcomes and mortality. Experimental evidence has shed light on thepathogenetic mechanisms of vascular calcification and arterial stiffness and their relation to impaired bone metabolismand imbalance between promoters and inhibitors of extra-osseous bone formation. However further research is needed toclarify their exact contribution and whether their targeting could significantly affect vascular calcification and arterialstiffening and could improve survival in chronic kidney disease patients.
机译:心血管疾病仍然是慢性肾脏病患者发病率和死亡率增加的主要原因,并且归因于在该患者人群中观察到的早期和加速动脉粥样硬化和动脉硬化。血管钙化,尤其是中层的钙化钙化通常在慢性尿毒症中发现并且是​​主要的导致动脉硬化和动脉僵硬度增加。流行病学数据支持血管钙化和动脉僵硬与不良心血管预后和死亡率之间的相关性。实验证据揭示了血管钙化和动脉僵硬的发病机制,以及它们与骨代谢受损以及骨外形成促进剂和抑制剂之间失衡的关系。但是,需要进一步的研究来阐明它们的确切作用以及它们的靶向作用是否会显着影响血管钙化和动脉硬化,并能改善慢性肾脏病患者的生存率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号